SIGA Stock News

SIGA Technologies, Inc. (NASDAQ:SIGA) Director James Antal sold 30,000 shares of the businesss stock in a transaction on Thursday, December 9th. The stock was sold at an average price of $7.82, for a total transaction of $234,600.00. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Shares []

SIGA Technologies (NASDAQ:SIGA) was downgraded by Zacks Investment Research from a buy rating to a hold rating in a note issued to investors on Thursday, Zacks.com reports. According to Zacks, SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and development of novel products for the prevention and [] The post SIGA Technologies (NASDAQ:SIGA) Stock Rating Lowered by Zacks Investment Research appeared first on ETF Daily News .

NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Healt

NEW YORK, Dec. 01, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Health Canada has approved oral TPOXX® (tecovirimat) as an extraordinary use new drug. Specifically, Health Canada has authorized the use of oral TPOXX for the treatment of human smallpox disease in adults and pediatric patients weighing at least 13 kg.

Charles Schwab Investment Management Inc. lowered its holdings in SIGA Technologies, Inc. (NASDAQ:SIGA) by 2.9% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 311,659 shares of the company’s stock after selling 9,245 shares during the quarter. Charles Schwab Investment Management Inc. owned 0.42% of […]

SIGA Technologies Inc. (NASDAQ:SIGA) shares, rose in value on Wednesday, 11/24/21, with the stock price down by -3.38% to the previous days close as strong demand from buyers drove the stock to $8.87. Actively observing the price movement in the last trading, the stock closed the session at $9.18, falling within a range of $8.835 SIGA Technologies Inc. (NASDAQ: SIGA) Offers Great Upside Read More »

Northern Trust Corp lowered its holdings in SIGA Technologies, Inc. (NASDAQ:SIGA) by 10.8% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 511,515 shares of the companys stock after selling 62,081 shares during the period. Northern Trust Corp owned approximately 0.68% of SIGA Technologies []

- Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications -

Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) published their summary opinion The post European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat appeared first on ForexTV .

Zacks Investment Research upgraded shares of SIGA Technologies (NASDAQ:SIGA) from a hold rating to a buy rating in a report issued on Friday, Zacks.com reports. The firm currently has $8.25 price objective on the stock. According to Zacks, SIGA Technologies Inc. is applying viral and bacterial genomics and sophisticated computational modeling in the design and []

SIGA Technologies, Inc.'s (SIGA) CEO Phillip Gomez on Q3 2021 Results - Earnings Call Transcript

NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced the exercise of a procurement option under its 75

NEW YORK, Sept. 07, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that Dr. Phil Gomez, the Company's Chief Executiv

SIGA Technologies, Inc. (SIGA) CEO Phil Gomez Q2 2021 Results - Earnings Call Transcript